Conformis, Inc. to Participate in the 2020 Wells Fargo Virtual Healthcare Conference
Conformis, Inc. (NASDAQ: CFMS) announced that its President and CEO, Mark Augusti, and the executive management team will participate in the 2020 Wells Fargo Virtual Healthcare Conference on September 9-10, 2020.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Conformis, Inc. (NASDAQ: CFMS) announced that its President and CEO, Mark Augusti, and the executive management team will participate in the 2020 Wells Fargo Virtual Healthcare Conference on September 9-10, 2020. The conference will feature one-on-one meetings, emphasizing Conformis' commitment to innovation in medical technology.
Conformis specializes in personalized joint replacement implants, utilizing its iFit Image-to-Implant technology. Its products, including the iTotal CR knee replacement system, have shown superior clinical outcomes, enhancing patient satisfaction compared to traditional implants.
Details
News Market Reaction – CFMS
The recorded move for CFMS in the trading session of this news was -0.57%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
BILLERICA, Mass., Sept. 02, 2020 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS) announced today that Mark Augusti, President and Chief Executive Officer, and members of the Company’s executive management team will participate in the 2020 Wells Fargo Virtual Healthcare Conference taking place September 9-10, 2020, in one-on-one meetings.
About Conformis, Inc.
Conformis is a medical technology company that uses its proprietary iFit Image-to-Implant technology platform to develop, manufacture, and sell joint replacement implants and instruments that are individually sized and shaped, which we refer to as personalized, individualized, or sometimes as customized, to fit each patient’s unique anatomy. Conformis offers a broad line of sterile, personalized knee and hip implants and single-use instruments delivered to hospitals and ambulatory surgical centers. In clinical studies, the Conformis iTotal CR knee replacement system demonstrated superior clinical outcomes, including better function and greater patient satisfaction, compared to traditional, off-the-shelf implants. Conformis owns or exclusively in-licenses issued patents and pending patent applications that cover personalized implants and patient-specific instrumentation for all major joints.
For more information, visit www.conformis.com. To receive future releases in e-mail alerts, sign up at ir.conformis.com.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.